Plasma Exosome RNA to Diagnose Prostate Cancer

Official record

Identifier

NCT06604130

Recruiting locations

country

China

Interventions studied

Prostate cancer screening decision

Lead sponsor

Xijing Hospital

Target enrolment

1600 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Enrolling by invitation

First posted

Sep 19, 2024

Last updated on the registry

Jul 30, 2026

Age

18 Years

Sex

MALE

Study contact

No public contact is listed on the official record.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

1. Blood prostate-specific antigen PSA\>4ng/dl;
2. Patients suspected of having prostate cancer through clinical symptoms, digital rectal examination, ultrasound examination, magnetic resonance imaging, and PSMA PET/CT examination.
3. The patient is willing to undergo prostate biopsy.

Exclusion Criteria:

1. Previous diagnosis of prostate cancer through prostate biopsy;
2. History of other malignant tumors in the past two years;
3. According to the research physician\'s judgment, serious complications may occur and affect the normal conduct of the experiment